• News

    Nodality presented novel data from its Immuno-Oncology program.

    Learn more

  • Services

    Enabling smarter drug development

    Learn more

  • PathPro™

    Nodality launched our TCR and CLL PathPro™ products in April 2015.

    Learn more

Recent News

Jul 08, 2015 Nodality Appoints Kathleen LaPorte as Chief Executive Officer. Read More

May 06, 2015 Nodality Launches PathPro™ TCR and BCR Panels for Assessing Drug Impact on Functional Signaling in Primary Human Cells. Read More

Apr 21, 2015 Nodality Publishes Study Results Confirming the Company’s Diagnostic Can Predict Induction Therapy Response in Elderly Patients with AML. Read More